Prokarium to present at the Tumour Microenvironment Conference in Berlin, November 1-2, 2022

Alexandra Sevko, Prokarium’s Director of Translational Research will be presenting at the Tumour Microenvironment Conference
Title: Salmonella Typhi ZH9 as a novel microbial immunotherapy for bladder cancer
When/Where: November 1st, 2.30pm CET; Emerging therapeutics opportunity in IO session

Related Events

Prokarium’s CEO, Kristen Albright, and COO, Dara Henry, will be in San Francisco 12th-16th January for J.P. Morgan...
Prokarium’s Chief Scientific Officer, Livija Deban, and VP of Research, Nick Glanville, are presenting at SITC 2024 in...
Prokarium’s CEO, Kristen Albright and COO, Dara Henry, to attend Bio-Europe 2024 in Stockholm November 4th-6th 2024.
Dara Henry, Prokarium’s COO, to attend BioJapan 2024 in Yokohama October 9th-11th 2024.